Joe
PS I haven't had coffee yet ...
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...
Continue Reading
Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...
Continue Reading
Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...
Continue Reading
Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...
Continue Reading
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
CGI Announces Strong Financial Results for Fourth Quarter Canadian IT and consulting giant CGI Inc. just released its fourth quarter and Fiscal 2025 results, showcasing a remarkable revenue growth of 9.7% year-over-year, amounting to $4.01 billion. This substantial increase in revenue reflects the effectiveness of CGI's strategic initiatives in a rapidly changing...
Continue Reading
Y-mAbs: A Pioneering Force in Radiopharmaceutical Innovation Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) continues to be at the forefront of biopharmaceutical innovation, particularly in the realm of radiopharmaceuticals. The company's latest announcement has generated buzz within the medical community as it announces a virtual Radiopharmaceutical Research and Development...
Continue Reading
TechnipFMC (NYSE:FTI) is set to roll out its quarterly earnings report on February 19, 2026, and desks are buzzing with anticipation—but not all that glitters is gold. Analysts are calling for an earnings per share (EPS) of $0.51, which might sound reasonable until you dig into the history here. The last quarter? TechnipFMC beat expectations by a mere $0.10—and still...
Continue Reading
Asetek's Latest Financial Results Asetek has reported its financial results for the third quarter of 2025, noting a revenue of $9.8 million. This figure shows a decline compared to the $12.2 million reported in the same quarter of 2024. The company has faced fewer shipments of liquid cooling products, which has significantly affected revenue over these periods. Gross...
Continue Reading
Toronto Hydro Corporation Reports Financial Growth for Q3 Toronto Hydro Corporation (Toronto Hydro) has recently unveiled its financial and operational results for the third quarter of 2025, marking a period of notable growth and strategic investment. During this quarter, net income after adjustments surged to $178.1 million, reflecting an impressive increase of $56.8...
Continue Reading